How to Build Productive, Strategic Sponsor-CRO Partnerships

Register free: http://www.pharmexec.com/pe_w/CRO

Event Overview:
The relationship between sponsors and CROs is strengthening as the outsourcing of trials becomes ever-more common. Making this connection as productive as possible means continuing the transition away from tactical projects toward strategic partnerships with both stakeholders having vested interest in greater operational efficiency. Key to this transition is open and transparent partner communications, building a foundation of trust and long-term commitment. However, many sponsor-CRO interactions are still fraught with inefficiencies and needless duplication of task ownership.

It’s in both parties’ interests to align their goals, structures, and processes in order to increase productivity, reduce costs, and ultimately deliver more successful studies.

Key Learning Objectives:

• Why communications and relationship management skills are so important to successful sponsor-CRO partnerships
• Why both data and process transparency are critical
• How cloud-based collaboration and analytics software can revolutionize the traditional clinical trial process
• Which attributes sponsors should consider when seeking a long-term, partner, and how CROs can position themselves apart from commodity service vendors

Speakers: Patrecia Flynn-Valone, Senior Director, Clinical Development Operations, Daiichi Sankyo, Inc

Helen Yeardley, Senior VP, Global Clinical Operations, ICON

Barry Milton, Head of Business Operations, Novartis Institutes for BioMedical Research

Tracy Mayer, Vice President and Global Head, Clinical Data Management and Connected Devices, IQVIA

Time and Date: Tuesday, April 27, 2021 at 1pm EDT | 12pm CDT | 10am PDT

On demand available after final airing until Apr. 27, 2022

Sponsor: Oracle Health Services

Register free: http://www.pharmexec.com/pe_w/CRO